Insider Trading History of Gupta Suneel

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gupta Suneel since 2019. This trader's CIK number is 1763923. At the time of last reporting, Gupta Suneel was the Chief Development Officer of Protagonist Therapeutics, Inc. (stock ticker symbol PTGX). Also see all insider trading activities at Protagonist Therapeutics, Inc.


Yearly summary of insider trading at Protagonist Therapeutics, Inc (PTGX) by Gupta Suneel

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 PTGX 0 $0 127,628 $5,760,429 210,450 $1,760,751
2023 PTGX 0 $0 0 $0 20,000 $147,600
2022 PTGX 0 $0 0 $0 40,000 $295,200
2019 PTGX 30,000 $153,900 0 $0 0 $0


Insider trading of Protagonist Therapeutics, Inc (PTGX) by Gupta Suneel

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-26 PTGX Sale 19,191 45.50 873,190
2024-11-25 PTGX Sale 103,437 46.04 4,762,239
2024-11-26 PTGX Option Ex 30,450 12.17 370,576
2024-11-25 PTGX Option Ex 175,000 7.73 1,353,275
2024-01-09 PTGX Sale 5,000 25.00 125,000
2024-01-09 PTGX Option Ex 5,000 7.38 36,900
2023-10-19 PTGX Option Ex 20,000 7.38 147,600
2022-04-26 PTGX Option Ex 40,000 7.38 295,200
2019-12-03 PTGX Buy 30,000 5.13 153,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gupta Suneel (Chief Development Officer of Protagonist Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.